Loading the security overview…
Where the tokens are
Standardised from the company’s filings, newest period first, labelled with the company’s own fiscal calendar. A line the company does not report is left off rather than shown as zero; margins and free cash flow are worked out here, and only where every input is present.
| Line item | Q2 FY262026-06-30 | Q1 FY262026-03-31 | Q4 FY252025-12-31 | Q3 FY252025-09-30 | Q2 FY252025-06-30 | Q1 FY252025-03-31 | Q4 FY242024-12-31 | Q3 FY242024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $50.47B | $50.18B | $49.75B | $50.71B | $49.78B | $48.89B | $45.44B | $45.11B |
| Cost of revenue | $37.02B | $35.62B | $38.07B | $38.14B | $36.71B | $35.31B | $33.50B | $32.95B |
| Gross profit | $13.45B | $14.57B | $11.68B | $12.57B | $13.07B | $13.58B | $11.94B | $12.16B |
| Gross margin | 26.6% | 29.0% | 23.5% | 24.8% | 26.3% | 27.8% | 26.3% | 27.0% |
| Selling, general and administrative | $5.55B | $6.33B | $5.42B | $5.27B | $5.00B | $5.30B | $4.80B | $5.27B |
| Operating expenses | $48.17B | $47.52B | $49.17B | $48.95B | $47.14B | $45.75B | $44.50B | $43.43B |
| Operating income | $2.30B | $2.66B | $581.00M | $1.76B | $2.63B | $3.14B | $946.00M | $1.67B |
| Operating margin | 4.6% | 5.3% | 1.2% | 3.5% | 5.3% | 6.4% | 2.1% | 3.7% |
| EBITDA | $2.67B | $3.02B | $987.00M | $2.14B | $3.01B | $3.51B | $1.34B | $2.00B |
| Interest expense | −$364.00M | −$357.00M | −$366.00M | −$351.00M | −$341.00M | −$344.00M | −$340.00M | −$300.00M |
| Income before taxes | $1.94B | $2.30B | $215.00M | $1.41B | $2.29B | $2.80B | $606.00M | $1.37B |
| Income taxes | $483.00M | $544.00M | −$331.00M | $219.00M | $548.00M | $613.00M | $193.00M | $365.00M |
| Net income | $1.45B | $1.76B | $546.00M | $1.19B | $1.74B | $2.18B | $413.00M | $1.01B |
| Net margin | 2.9% | 3.5% | 1.1% | 2.3% | 3.5% | 4.5% | 0.9% | 2.2% |
| EPS, basic | $6.74 | $8.03 | $2.47 | $5.32 | $7.74 | $9.64 | $1.83 | $4.38 |
| EPS, diluted | $6.71 | $8.00 | $2.47 | $5.32 | $7.72 | $9.61 | $1.81 | $4.36 |
| Diluted shares | 217.90M | 220.40M | 221.70M | 223.70M | 225.80M | 227.20M | 230.90M | 233.10M |
Figures describe Elevance Health shares, not any token. As of Jul 15, 2026, from Massive's standardised financials. The company reports these figures; a token's issuer holds the shares and reports nothing of its own here.